Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
NCT00771615
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
469
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
GSK A/turkey H5N1 Influenza vaccine
Sponsor
GlaxoSmithKline